QQQ   320.44 (-0.97%)
AAPL   125.85 (-1.52%)
MSFT   234.28 (-1.12%)
FB   263.76 (-0.43%)
GOOGL   2,069.43 (-0.01%)
TSLA   703.42 (-2.09%)
AMZN   3,129.86 (-0.52%)
NVDA   544.98 (-1.57%)
BABA   238.14 (-1.47%)
CGC   36.07 (+3.86%)
GE   13.03 (-0.61%)
MU   92.02 (-2.89%)
NIO   44.73 (-10.11%)
AMD   85.46 (-1.08%)
T   28.34 (+0.89%)
F   12.36 (+3.17%)
ACB   11.51 (+4.26%)
DIS   194.20 (-0.40%)
BA   223.15 (-0.55%)
NFLX   549.52 (-0.20%)
BAC   35.53 (-0.73%)
QQQ   320.44 (-0.97%)
AAPL   125.85 (-1.52%)
MSFT   234.28 (-1.12%)
FB   263.76 (-0.43%)
GOOGL   2,069.43 (-0.01%)
TSLA   703.42 (-2.09%)
AMZN   3,129.86 (-0.52%)
NVDA   544.98 (-1.57%)
BABA   238.14 (-1.47%)
CGC   36.07 (+3.86%)
GE   13.03 (-0.61%)
MU   92.02 (-2.89%)
NIO   44.73 (-10.11%)
AMD   85.46 (-1.08%)
T   28.34 (+0.89%)
F   12.36 (+3.17%)
ACB   11.51 (+4.26%)
DIS   194.20 (-0.40%)
BA   223.15 (-0.55%)
NFLX   549.52 (-0.20%)
BAC   35.53 (-0.73%)
QQQ   320.44 (-0.97%)
AAPL   125.85 (-1.52%)
MSFT   234.28 (-1.12%)
FB   263.76 (-0.43%)
GOOGL   2,069.43 (-0.01%)
TSLA   703.42 (-2.09%)
AMZN   3,129.86 (-0.52%)
NVDA   544.98 (-1.57%)
BABA   238.14 (-1.47%)
CGC   36.07 (+3.86%)
GE   13.03 (-0.61%)
MU   92.02 (-2.89%)
NIO   44.73 (-10.11%)
AMD   85.46 (-1.08%)
T   28.34 (+0.89%)
F   12.36 (+3.17%)
ACB   11.51 (+4.26%)
DIS   194.20 (-0.40%)
BA   223.15 (-0.55%)
NFLX   549.52 (-0.20%)
BAC   35.53 (-0.73%)
QQQ   320.44 (-0.97%)
AAPL   125.85 (-1.52%)
MSFT   234.28 (-1.12%)
FB   263.76 (-0.43%)
GOOGL   2,069.43 (-0.01%)
TSLA   703.42 (-2.09%)
AMZN   3,129.86 (-0.52%)
NVDA   544.98 (-1.57%)
BABA   238.14 (-1.47%)
CGC   36.07 (+3.86%)
GE   13.03 (-0.61%)
MU   92.02 (-2.89%)
NIO   44.73 (-10.11%)
AMD   85.46 (-1.08%)
T   28.34 (+0.89%)
F   12.36 (+3.17%)
ACB   11.51 (+4.26%)
DIS   194.20 (-0.40%)
BA   223.15 (-0.55%)
NFLX   549.52 (-0.20%)
BAC   35.53 (-0.73%)
Log in
NASDAQ:BBIO

BridgeBio Pharma Short Interest Ratio and Short Volume

$68.57
-3.34 (-4.64 %)
(As of 03/2/2021 11:56 AM ET)
Add
Compare
Today's Range
$68.46
Now: $68.57
$70.97
50-Day Range
$55.47
MA: $66.18
$72.35
52-Week Range
$14.23
Now: $68.57
$73.50
Volume51,535 shs
Average Volume1.18 million shs
Market Capitalization$10.20 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.82

Short Interest

BridgeBio Pharma (NASDAQ:BBIO) Short Interest Data

Current Short Volume11,330,000 shares
Previous Short Volume11,850,000 shares
Change Vs. Previous Month:-4.39%
Dollar Volume Sold Short$800.80 million
Short Interest Ratio / Days to Cover12.8
Last Record DateFebruary, 12 2021
Outstanding Shares120,500,000 shares
Float Size94,780,000 shares
Short Percent of Float11.95%
Today's Trading Volume51,535 shares
Average Trading Volume1,179,313 shares
Today's Volume Vs. Average-95.63%

Short Interest Over Time


BridgeBio Pharma (NASDAQ:BBIO) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/202111,330,000 shares $800.80 million -4.4%12.0%12.8 $70.68
1/29/202111,850,000 shares $816.11 million -0.4%15.9%13.9 $68.87
1/15/202111,900,000 shares $669.97 million +10.7%15.9%15.5 $56.30
12/31/202010,980,000 shares $753.01 million No Change14.7%15.7 $68.58
12/15/202010,980,000 shares $714.25 million No Change14.7%15.7 $65.05
11/30/202010,980,000 shares $713.37 million +1.9%14.8%14.4 $64.97
11/15/202010,780,000 shares $541.59 million +0.2%14.5%15 $50.24
10/30/202010,760,000 shares $468.28 million -2.5%36.3%16.1 $43.52
10/15/202011,040,000 shares $438.95 million +3.8%37.5%17.1 $39.76
9/30/202010,640,000 shares $422.73 million -3.5%14.3%17.3 $39.73
9/15/202011,020,000 shares $403.99 million -2.5%14.9%19.6 $36.66
8/31/202011,300,000 shares $378.44 million -4.5%15.3%19.7 $33.49
8/14/202011,830,000 shares $326.74 million +0.9%16.0%18.3 $27.62
7/31/202011,730,000 shares $342.99 million -0.1%16.1%17.7 $29.24
7/15/202011,740,000 shares $330.36 million +4.0%16.1%17.4 $28.14
6/30/202011,290,000 shares $341.52 million +29.2%15.5%15.2 $30.25
6/15/20208,740,000 shares $267.44 million -1.8%12.0%11.2 $30.60
5/29/20208,900,000 shares $293.34 million +3.0%12.2%9.6 $32.96
5/15/20208,640,000 shares $253.41 million +1.8%12.3%8.6 $29.33
4/30/20208,490,000 shares $303.01 million -1.6%11.9%8.5 $35.69
4/15/20208,630,000 shares $284.62 million -6.3%12.1%8.9 $32.98
3/31/20209,210,000 shares $286.34 million +45.9%12.7%10.2 $31.09
3/13/20206,311,900 shares $179.13 million +71.5%N/A3.8 $28.38
2/28/20203,680,000 shares $89.02 million +0.8%N/A6.1 $24.19
2/14/20203,650,000 shares $103.95 million -9.0%5.1%9 $28.48

BridgeBio Pharma (NASDAQ:BBIO) Short Interest FAQ

speech bubbles
speech bubbles











What is BridgeBio Pharma's current short interest?

Short interest is the volume of BridgeBio Pharma shares that have been sold short but have not yet been covered or closed out. As of February 12th, investors have sold 11,330,000 shares of BBIO short. 11.95% of BridgeBio Pharma's shares are currently sold short. View details.

What is a good short interest ratio for BridgeBio Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BridgeBio Pharma currently has a short interest ratio of 13.0.

What is a good short interest percentage for BridgeBio Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.95% of BridgeBio Pharma's floating shares are currently sold short.

Is BridgeBio Pharma's short interest increasing or decreasing?

BridgeBio Pharma saw a drop in short interest in February. As of February 12th, there was short interest totaling 11,330,000 shares, a drop of 4.4% from the previous total of 11,850,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is BridgeBio Pharma's float size?

BridgeBio Pharma currently has issued a total of 148,791,000 shares. Some of BridgeBio Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BridgeBio Pharma currently has a public float of 94,780,000 shares.

How does BridgeBio Pharma's short interest compare to its competitors?

11.95% of BridgeBio Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BridgeBio Pharma: Alexion Pharmaceuticals, Inc. (3.61%), Shiseido Company, Limited (0.00%), Astellas Pharma Inc. (0.00%), BeiGene, Ltd. (0.00%), Genmab A/S (0.00%), Genmab A/S (0.00%), MERCK Kommanditgesellschaft auf Aktien (0.00%), UCB SA (0.00%), Horizon Therapeutics Public Limited (0.00%), and Catalent, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short BridgeBio Pharma stock?

Short selling BBIO is an investing strategy that aims to generate trading profit from BridgeBio Pharma as its price is falling. BridgeBio Pharma's stock is trading down $3.34 today. To short BridgeBio Pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that BridgeBio Pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BridgeBio Pharma?

A short squeeze for BridgeBio Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BBIO, which in turn drives the price of the stock up even further.

How often is BridgeBio Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBIO, twice per month. The most recent reporting period available is February, 12 2021.



This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.